Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,753,196
-
Share change
-
-1,108,582
-
Total reported value
-
$18,143,135
-
Price per share
-
$1.69
-
Number of holders
-
27
-
Value change
-
-$2,278,450
-
Number of buys
-
11
-
Number of sells
-
15
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q4 2015
As of 31 Dec 2015,
CYMABAY THERAPEUTICS INC - COM (CBAY) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,753,196 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP LLC, Abingworth LLP, Lombard Odier Asset Management (USA) Corp, Versant Venture Management, LLC, Point72 Asset Management, L.P., KINGDON CAPITAL MANAGEMENT, L.L.C., Omega Fund Management, LLC, SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, and J. Goldman & Co LP.
This page lists
27
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.